On May 23, Enifer announced it has received €36 million ($39 million USD) in funding to construct a unique, food-grade mycoprotein facility in Kantvik, Kirkkonummi, Finland. This facility will be the world’s first commercial plant to convert side stream raw materials from the food industry into a fungi-based protein called PEKILO®. The series B funding round, led by Taaleri Bioindustry Fund I, raised €15 million ($16.3 million USD), with additional support from the Finnish Climate Fund, Finnvera, and Business Finland. The €33 million ($35.8 million USD) facility is set to produce up to 3,000 tons of PEKILO annually, catering to the protein needs of about 40,000 people. Expected to be completed by the end of 2025, the facility will begin operations in 2026 and will feature a full-sized industrial fermenter. PEKILO offers a sustainable protein alternative with minimal environmental impact, and Enifer plans to file for Novel Foods approval later this year, with expected approval in 2026.
Advertisement
